Soprano@Soprano

3Wk

Have you read up on who the stuff is actually intended for and who the most important target groups of "prep" are?

Show original (German)

Like••Answer

Tenbagger2024@Tenbagger2024

3Wk

@Soprano
The company has a large pipeline, so not just the one drug.
I took a look at the estimates.
Earnings per share go up from 4.39 to 7.48.
Free cash flow from 9397.86 to 10433.23
EbiT margin from 29 to 43
Turnover continues to rise.
The P/E ratio falls to 13

Show original (German)

Like•

👍

11

•Answer

DerJude@DerJude

2Wk

@Tenbagger2024 I've been in it myself since €59.26 😊

Show original (German)

Like••Answer

Tenbagger2024@Tenbagger2024

2Wk

@Ni485
Cool my dear,
Fundamentally, it doesn't look too bad.

Show original (German)

Like••Answer